April 18, 2024



Johnson & Johnson expects $2.5 billion in global sales from Covid vaccine this year


By Berkeley Lovelace Jr.

July 21, 2021

Johnson & Johnson said Wednesday it expects to sell $2.5 billion of its Covid-19 vaccine this year, even as concerns mount over the shot’s effectiveness against the delta variant.

In releasing its second-quarter financial results, the company also reported earnings and revenue that beat Wall Street’s expectations.

Read more…